Quantcast

Latest Euglenozoa Stories

2009-11-03 14:20:38

Using an unconventional approach that they designed, University of Pittsburgh drug discoverers and their collaborators at Walter Reed Army Institute of Research have identified compounds that hold promise for treating leishmaniasis, a parasitic infection that many consider one of the world's most overlooked diseases. The findings are available online today in PLoS Neglected Tropical Diseases. These drug candidates, which are able to disrupt the growth of a certain stage in the life cycle of...

2009-10-23 14:12:03

Professor Albert Descoteaux's team at Centre INRS "“ Institut Armand-Frappier has gained a better understanding of how the Leishmania donovani parasite manages to outsmart the human immune system and proliferate with impunity, causing visceral leishmaniasis, a chronic infection that is potentially fatal if left untreated. This scientific breakthrough was recently published in PLoS Pathogens. Some 350 million people live in areas where leishmaniasis can be contracted. Over 90% of cases...

2009-10-07 08:28:37

Researchers at MUHC/McGill uncover key role played by a molecule in the process of infection used by the parasite that causes leishmania Leishmania is a deadly parasitic disease that affects over 12 million people worldwide, with more than 2 million new cases reported every year. Until recently, scientists were unsure exactly how the parasite survives inside human cells. That mystery has now been solved according to a new study published in Science Signaling by a team led by Dr. Martin...

2009-08-27 08:00:00

SEATTLE, Aug. 27 /PRNewswire-USNewswire/ -- IDRI (Infectious Disease Research Institute) announced today the start of a clinical trial in Sudan to test its leishmaniasis vaccine candidate for the treatment of post kala-azar dermal leishmaniasis (PKDL), a complication of visceral leishmaniasis (VL) which is observed in 50% of patients treated for VL in the country, predominantly affecting children. This trial reflects IDRI's commitment to develop innovative, affordable products against all...

2009-08-21 08:19:11

The parasites that cause leishmaniasis use a quirky trick to convince the immune system to effectively invite them into cells for dinner, according to a new study published today in PLoS Pathogens. The researchers, from Imperial College London, say their findings improve understanding of the way Leishmania parasites establish an infection and could aid the search for a vaccine against this neglected tropical disease.Leishmania parasites are transmitted by sand flies. After the parasites...

2009-08-17 02:00:00

LEIDEN, The Netherlands, August 17 /PRNewswire/ -- A new consortium has been formed to boost drug development for the treatment of two deadly diseases, African sleeping sickness and Leishmaniasis, which affect millions of people worldwide. A total budget of nearly 3.6 million euros has been allocated over the next 4 years, to develop effective drugs for these diseases. The consortium includes IOTA Pharmaceuticals, Mercachem, Nycomed, the Drugs for Neglected Diseases initiative, the Royal...

2009-04-16 07:39:43

Double-stranded DNA breaks are the key to Trypanosoma brucei's getaway planThe parasite Trypanosoma brucei, which causes African sleeping sickness, is like a thief donning a disguise. Every time the host's immune cells get close to destroying the parasite, it escapes detection by rearranging its DNA and changing its appearance. Now, in research to appear in the advance online April 15 issue of Nature, two laboratories at Rockefeller University have joined forces to reveal how the parasite...

ac6e852eb1a74098f4db2722b72b208b1
2009-04-10 08:16:07

For years, microbiologist Stephen Beverley, Ph.D., has tried to get the disease-causing parasite Leishmania in the mood for love. In this week's Science, he and colleagues at the National Institutes of Health report that they may have finally found the answer: Cram enough Leishmania into the gut of an insect known as the sand fly, and the parasite will have sex. Some strains of the parasite are deadly and kill hundreds of thousands of people annually in developing countries. Offspring of the...

2009-03-05 07:00:00

SAN ANTONIO, March 5 /PRNewswire/ -- A plentiful, inexpensive, topical compound is as effective at treating the skin lesions of Middle Eastern and African leishmaniasis as is the standard therapy, a less-available, costlier compound injected into lesions. That's one of the findings of a research team from Johns Hopkins University, Harvard University, Thomas Jefferson University and led by Reza F. Ghohestani, M.D., Ph.D., director of the Texas Institute of Dermatology and an associate...

2009-01-22 08:00:00

SEATTLE, Jan. 22 /PRNewswire/ -- IDRI (Infectious Disease Research Institute) announced it has granted the Instituto Butantan, a Brazilian biomedical research institution, an exclusive license in Latin America and a non-exclusive license in the rest of the world to use two of IDRI's lead vaccine antigen candidates for the prevention and treatment of leishmaniasis in humans and dogs. IDRI will provide technical assistance to the Instituto Butantan for the development and evaluation of the...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.